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Abstract: The macronutrient component of diets is critical for metabolic control and 
insulin action. The aim of this study was to compare the effects of high fat diets (HFDs) vs. 
high carbohydrate diets (HCDs) on metabolic control and insulin resistance in Wistar rats. 
Thirty animals divided into five groups (n = 6) were fed: (1) Control diet (CD); (2) High-
saturated fat diet (HSFD); (3) High-unsaturated fat diet (HUFD); (4) High-digestible starch 
diet, (HDSD); and (5) High-resistant starch diet (HRSD) during eight weeks. HFDs and 
HCDs reduced weight gain in comparison with CD, however no statistical significance was 
reached. Calorie intake was similar in both HFDs and CD, but rats receiving HCDs showed 
higher calorie consumption than other groups, (p < 0.01). HRSD showed the lowest levels 
of serum and hepatic lipids. The HUFD induced the lowest fasting glycemia levels and 
HOMA-IR values. The HDSD group exhibited the highest insulin resistance and hepatic 
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cholesterol content. In conclusion, HUFD exhibited the most beneficial effects on 
glycemic control meanwhile HRSD induced the highest reduction on lipid content and did 
not modify insulin sensitivity. In both groups, HFDs and HCDs, the diet constituents were 
more important factors than caloric intake for metabolic disturbance and insulin resistance. 
Keywords: metabolic control; high-carbohydrate diet; high-fat diet; resistant starch; 
insulin resistance  
 
1. Introduction  
The importance of nutrient composition has been more widely recognized on account of dysmetabolic 
diseases such as obesity and diabetes, which are directly related to the incidence of cardiovascular 
disease. Obesity is considered a serious disease affecting a large population worldwide [1,2]. Insulin 
resistance (IR) is considered the key mechanism unifying obesity, diabetes and heart disease [3]. In the 
course of months or years, IR is followed by the increase in β-cell insulin secretion and by several 
complications known as the insulin resistance syndrome, which is associated with dyslipidemia, 
hypertension, hyperglycemia and cardiovascular disease [4]. Thus, efforts are continuously underway 
to prevent obesity in the population. Although weight gain is ultimately the result of an overall positive 
energy balance, the environmental and genetic interplay that accounts for the dramatic rise in obesity is 
not fully understood. Although the traditional weight loss approach advises a high carbohydrate low 
fat diet, a very low carbohydrate high fat diet has been suggested to have greater effectiveness in 
weight loss and metabolic improvement [5-7]. One potential problem associated with chronic ingestion 
of a low-carbohydrate diet is that it usually contains a high percentage of fat to compensate for 
carbohydrate-calorie reduction, and most in the form of saturated fat [8]. High-saturated fat diet in 
humans is known to be associated with high risk of diabetes and cardiovascular disease [9,10]. In rats a 
high-saturated fat diet is used as a diabetogenic factor increasing insulin and lipid levels and it has 
been shown to induce severe insulin resistance in skeletal muscles [11-13]. In general, most studies on 
nutrition research have been focused on studying food fat content and less have been concentrated on 
the importance of carbohydrate composition for glucose homeostasis and insulin resistance [14]. The 
disadvantage of consuming simple sugars (like monosaccharides and disaccharides) was understood 
and it was recommended to include complex carbohydrates in the diet. This point of view changed in 
recent years, because the digestibility of complex carbohydrates and dietary fiber, became known, the 
concept of resistant starch emerged, and the concept of glycemic index also emerged [15-17]. 
In 2009, the Codex Alimentarius Commision’s Committee on Nutrition and Foods for Special 
Dietary Uses, adopted a new definition of dietary fiber as “carbohydrate polymers with 10 or more 
monomeric units, which are not hydrolized by the endogenous enzymes in the small intestine of 
humans” [18]. Thus, resistant starch (RS), which is the portion of starch that resists digestion in the 
small intestine, is a recently recognized source of fiber and it is classified as a fiber component which 
reaches partial or complete fermentation in the colon.  
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Unripe-banana is known to be the non-manufactured food with the highest resistant starch content. 
The native banana starch (NBS) obtained from unripe banana (Musa cavendish AAA) in Tabasco, 
Mexico exhibits a low glycemic index (22.4) and a high resistant starch content (32%). In previous 
studies this product has demonstrated beneficial effects on body weight reduction and glucose 
homeostasis in animal models and humans [19-21].  
Although the differential effects of high-saturated vs. high-unsaturated fat diets have become 
known, fewer studies have been focused on the differential effects of complex carbohydrates on 
metabolic control. In addition, there are no studies comparing unbalanced diets composed of normal 
banana starch or digestible starch with those containing high fat on metabolic control and insulin 
resistance. The aim of this study was to compare the effects of high-carbohydrate diets containing NBS 
or digestible starch with those containing high fat on the metabolic control and insulin resistance in 
normal Wistar rats.  
2. Material and Methods 
2.1. Materials 
Casein was purchased from Novag Infancia (Mexico City), Lard (Keken) was obtained from Grupo 
Porcicola Mexicano (Yucatan, Mexico). Extra virgin olive oil was obtained from Carbonell (Spain) 
imported by Arroz SOS de Mexico, 13.3% saturated fatty acids, 6.6% poliunsaturated fatty acids 
(PUFAs) and 73.3% monounsaturated fatty acids (MUFAs). Corn oil (Mazola) from Alimentos 
Capullo. Corn starch was purchased from Unilever de Mexico. Native banana starch was provided by 
the Centro de Investigaciones Agropecuarias, Universidad Juarez Autonoma de Tabasco, situated in 
Teapa, Tabasco. NBS was obtained from unripe (green) bananas (Musa cavendish AAA) by a 
previously described procedure [21]. Resistant starch content measured according to the Association of 
Official Analytical Chemists (AOAC) 2002.02 method (Megazyme International Ireland Ltd was 
found to be 34% on a dry weight basis and the glycemic index was 22.4. 
2.2. Animals and Diets 
Male Wistar rats (n = 30) were obtained from the breeding colony maintained by the Unidad de 
Producción, Cuidado y Experimentacion Animal (UPCEA), from the División Académica de Ciencias 
de la Salud (DACS), Universidad Juárez Autonoma de Tabasco (UJAT), verified by the Secretaria de 
Agricultura, Ganaderia y Recursos Pecuarios (SAGARPA 2005). All procedures were subject to 
regulations of animal experimentation from the Norma Oficial Mexicana NOM-062-ZOO-1999, and 
the International Guide for Caring and Use of Laboratory Animals NRC 2002. Rats at the age of  
7 weeks and 180–200 g body weight were maintained at their housing conditions with a controlled 
humidity (55%) and a 21 ± 1 °C temperature, 12–12 h light-dark. Animals were switched to one of the 
five different experimental diets: Control diet (CD, 2018S Teklad Global 18% Protein Rodent Diet 
from Harlan Laboratories), high-saturated fat diet (HSFD), high-unsaturated fat diet (HUFD),   
high-digestible starch diet (HDSD) and high-resistant starch diet (HRSD). Multiple cages were used 
being six animals by group. In this way, two different high-fat diets (HFDs) and two high-carbohydrates 
diets (HCDs) were administered in comparison with the control diet (CD). The 2018S Teklad Rodent Int. J. Environ. Res. Public Health 2012, 9  1666 
 
 
Diet contained as percentage of calories 18.6% proteins, 44.2% carbohydrates and 6.2% fat. The 
energy content of this diet was 3.8 Kcal/g. The HFDs consisted of a high-saturated fat diet (HSFD) 
containing 58% lard and the high-unsaturated fat diet (HUFD) containing 58% olive oil. The HCDs 
consisted of a high-digestible carbohydrate diet (HDCD) containing 67% digestible corn starch and the 
high-resistant starch diet with 67% native banana starch (NBS). Animals were given free access to 
water and diets during the eight week duration of the experiments. Table 1 shows the details of diet 
composition. Diets were freshly prepared each day as pellets and the ingredients were separately stored 
at 4 °C. The energy intake was measured for each group from the 24 h food intakes calculated from the 
differences in daily food weighs. Individual body weight of rats in each group was assessed twice a week. 
Table 1. Diet composition. 
   HSFD  HUFD  HDSD  HRSD 
   g/Kg g/Kg g/Kg g/Kg 
Protein 
Casein  254.1 254.1 212.9 212.9 
Lipid 
Corn oil  11.1  11.1 
Olive oil  364.5 
Lard 364.5 
Carbohydrates 
Corn starch  305  305  675 
Banana starch  675 
Sucrose 33.8  33.8  67  67 
Vit. & Min.  15  15  15  15 
Caloric value (Kcal/g)  5.6  5.6  3.9  3.9 
CD, control diet; HSFD, high-saturated fat diet; HUFD, high-unsaturated fat diet; HDSD, high-digestible 
starch diet; HRSD, high-resistant starch diet. High-fat diets contained as percentage of calories 18% proteins, 
24% carbohydrates, 58% fat and high-carbohydrate diets: 21.8% proteins, 75.6% carbohydrate, 2.5% fat. 
2.3. Oral Glucose Tolerance Test 
Two days before finishing experimentation (day 54) an oral glucose tolerance test (OGTT) using 
glucose 1 g/Kg BW was performed after a 12 h fasting period. Blood glucose concentration from the 
tail vein was measured using the Accu-Chek blood glucose meter (Roche Diagnostics, Mainz-Hechtsheim, 
Germany) at 0, 30, 60, 90 and 120 min.  
2.4. Rat Euthanization and Sample Collection 
At the end of the 8-week dietary period food was removed at the end of the dark period (0700)  
and animals left 12 h fasting until 0800 to begin experimentation. Rats were anesthetized with 
intraperitoneal pentobarbital sodium (60 mg/Kg body weight). Blood samples were obtained from the 
jugular vein and were rapidly centrifuged, plasma was either immediately used or stored at −20 °C 
during 7 days. The liver was totally removed, weighted and used for biochemical determinations.  
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2.5. Biochemical Measurements 
Glucose, cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein 
cholesterol (HDL-C) and triglycerides were analyzed by using an Architect Clinical Chemistry 
Autoanalyzer System from Abbott Clinical Chemistry (Chicago, IL, USA). Insulin was measured by 
the Rat Insulin ELISA kit (IBL International GMBH, Hamburg, Germany). Insulin resistance was 
estimated according to the Homeostasis Model Assessment (HOMA-IR) which was calculated by the 
product of the fasting concentrations of glucose (mg/dL) and insulin (μU/mL) divided by 405 [22]. 
Hepatic lipids were extracted using the Folch method [23]. Lipid extracts were resuspended for 
measurements of cholesterol and triglycerides by immunoenzymatic assays.  
2.6. Statistical Analysis 
Data are expressed as mean ± SEM. One-way analysis of variance (ANOVA) was used to compare 
data among groups. When a statistically significant difference was encountered, a Bonferroni’s 
multiple comparison test was performed. The total OGTT area under the curve (AUC) was calculated 
using the trapezoid method. Statistical significance was defined as p < 0.05. The calculation   
was performed using GraphPAD PRISMA software version 5.01 (Graphpad Software, Inc., San Diego, 
CA, USA). 
3. Results  
3.1. Body Weight and Energy Intake 
Figure 1 shows the body weight changes through the experimental period and their respective areas 
under the curves (AUCs). At the onset of the experiment, all the animals included in the five study 
groups had similar body weights. Body weight gain in the CD group was progressively higher than in 
the other groups, but no statistically significant differences were observed when the AUCs for body 
weight were compared between groups (Figure 1). At the end of the experimental period, the CD 
group showed body weight gain higher than the HSFD, HUFD and HRSD groups (p < 0.05), however, 
no significant difference was reached with the HDSD. No significant difference between HFDs and 
HCDs groups were observed. Table 2 presents the data of final body weight and the average of total 
energy intake over the experimental period by group of animals. Animals receiving HFDs showed total 
caloric intake similar to the CD group but lower than the HCDs (p < 0.001). Despite the higher caloric 
intake in the HCDs groups relative to the HFDs groups, no differences in body weight gain were 
observed among them. The HRSD group showed the highest caloric intake in comparison with the 
other groups, including the HDSD (p < 0.001). There were not significant differences in body weight 
gain and total caloric intake between the HSFD and the HUFD groups. 
3.2. Glycemic Control 
Table 3 shows the effects of experimental diets on parameters related to glycemic control. HUFD 
group exhibited the lowest fasting glycemia levels among all groups, however, it was only significant 
when compared to the HRSD group.  I
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Table 4. Effects of experimental diets on serum lipids.  
Variable CD  HSFD  HUFD HDSD  HRSD 
TAG (mg/dL)  118 ± 17.1 
a  67 ± 6.8 
c  65 ± 9.2  147 ± 17.9 
B,c 55  ±9.4 
a,B 
Chol (mg/dL)  73 ± 4.1  73 ± 4.5  81 ± 3.3 
A  70 ± 4.9  50 ± 2.6
A 
HDL-Chol (mg/dL)  30 ± 1.2  34 ± 1.9 
b  35 ± 1.6 
a  31 ± 2.0  26 ± 0.8 
a,b 
Values are mean ± SEM, n = 6. Means in a row with superscripts with a common letter differ, (small letter,  
p < 0.05 or capital letter, p < 0.01). CD, control diet; HSFD, high-saturated fat diet; HUFD, high-unsaturated 
fat diet; HDSD, high-digestible starch diet; HRSD, high-resistant starch diet. ANOVA and Bonferroni’s 
multiple comparison test. 
3.4. Hepatic Determinations 
No differences on total liver weight were observed between the groups after the experimental 
period (data not shown). Table 5 shows that liver total lipids in HFDs increased compared with other 
groups, however, only the HUFD group reached significance respect to CD, HDSD, and HRSD groups 
(p < 0.01). The liver total lipids in the HSFD group increased significantly only in comparison with the 
HRSD group (p < 0.01). There were not differences in HDSD and HRSD compared with the CD group. 
Table 5. Effects of experimental diets on hepatic lipids. 
Values are means ± SEM, n = 6. Means in a row with superscripts with a common letter differ, (small letter, 
p < 0.05 or capital letter, p < 0.01). CD, control diet; HSFD, high-saturated fat diet; HUFD, high-unsaturated 
fat diet; HDSD, high-digestible starch diet; HRSD, high-resistant starch diet. ANOVA and Bonferroni’s 
multiple comparison test. 
Hepatic cholesterol levels increased after the HSFD and the HDSD treatments, however did not 
reach significant statistical difference from the CD group. On the other hand the lowest cholesterol 
value was observed in the HRSD group which was significantly lower in comparison with HSFD and 
HDSD groups. 
Hepatic triglyceride levels were significantly higher in the HSFD and the HDSD groups in 
comparison with the CD group (p < 0.05); also HSFD was higher than HUFD (p < 0.05) and HDSD 
was higher than the HRSD group (p < 0.05). HRSD and HUFD triglyceride levels were not different 
from the values in CD group. 
4. Discussion 
Most experiments in nutrition research have analyzed the differential effects of high-fat diets on 
metabolic control, but few studies have focused on complex carbohydrates. Typically diets containing 
simple carbohydrates like sucrose are compared with diets containing digestible starch. In the present 
study, the effects of two different HCDs and two HFDs on energy balance, metabolic control and 
insulin resistance in a group of normal Wistar rats were analyzed in comparison with rats fed a normal 
Variable (mg/g)  CD  HSFD HUFD HDSD  HRSD 
Total Lipids   36 ± 1.3 
A  50 ± 3.4 
B  58 ± 2.3 
A,C,D  39 ± 3.3 
D  29 ± 0.7 
B,C 
CHOL   2.1 ± 0.08  3.0 ± 0.07 
a  2.2 ± 0.1  3.0 ± 0.2
 b  1.9 ± 0.09 
a,b 
TAG  2.9 ± 0.2 
c,d  3.6 ± 0.6 
a,d,f  2.8 ± 0.4 
a,b  3.7 ± 1.1 
b,c,e  2.9 ± 0.4 
e,f Int. J. Environ. Res. Public Health 2012, 9  1671 
 
 
standard diet. To achieve this goal a group of animals fed a high-resistant starch diet in comparison 
with a high-digestible-starch diet and the HFDs were included. In previous experiments our group 
showed the beneficial effects of the native banana starch (NBS) used in this study improving metabolic 
control, reducing blood lipids and body weight in rats as well as in obese subjects [19-21]. 
This study was performed in normal growing rats (7 weeks of age) in the middle of the adolescence 
to the adult period. Hence, it might be supposed that the reduction in body weight gain observed in the 
experimental diets compared to CD group, primarily reflect the reduction of growth rather than 
reduction of obesity since the animals were not obese. The body weight AUCs did not show significant 
differences, even though the rats fed the HCDs exhibited higher caloric consumption, HRSD group 
with more than 200% and the HDSD group with an energy intake of more than 50% compared with 
the other groups. At the end of the experimental period the reduction of body weight gain was more 
moderate in the HDSD group. However, comparison in food consumption with the CD group must be 
interpreted with care because the preparation of the diets. The CD was administered as pellets as 
purchased from Harlan laboratories, however, all the other diets were daily freshly prepared as pellets. 
Thus, differences in the consistency of the food could have introduced differences in food consumption 
when compared to CD group. Of note, HDSD final body weight was not statistically different from the 
CD group. These findings cannot be attributed to the high-calorie consumption since the HRSD had 
higher consumption than the CD group but lower body weight gain. This moderate differential effect 
on body weight in the HCDs, might be partially explained by an increased accumulation of body fat, 
however, this was not measured in this study.  
As mentioned above, energy intake in this study was measured by the difference among the daily 
food weights and resulted in values between 1.1 and 4.2 g/day which might appear at first sight too 
high to reach, in special in the case of the HRSD group which observed the highest values. However, 
this can be partially explained by the reduced energy density of this diet in comparison with the HCDs. 
Moreover, it should be noted that, due to its resistance to digestion, the caloric availability of RS is 
even lower than that for digestible starches. Most digestible carbohydrates provide 4 Kcal of available 
energy/g (value used in Table 1) whereas RS provides 2–3 Kcal/g. Considering that NBS contains only 
34% of resistant starch, the corrected caloric density of the HRSD could be near to 3.6 Kcal/g.  
Besides, another mechanism to explain the difference in the energy intake consumption between the 
HFDs and the HCDs might be the higher satiating effect of the HFDs because of their slower digestion 
in comparison with the HCDs rendering rats more efficient with their ingested calories [24,25]. 
However, the anorexigenic effect of some low-carbohydrate diets mediated by the production of 
ketones was not expected in this study because the carbohydrates content in these diets are not enough 
to induce ketogenesis. On the other hand, the high consumption of NBS observed in the HRSD group 
here, could be in contrast with others who have informed that a high amylose diet reduce energy intake 
in obese rats fed ad libitum in comparison with a high amylopectin diet [26]. Others have also 
informed beneficial effects of resistant starch in humans increasing satiety [27,28]. This findings 
warrant further studies to determine NBS satiety and satiation since the current study was not designed 
for that purpose. Studies in humans have demonstrated that both of them HFDs or HCDs reduces body 
weight similarly. However, in some cases, the HFDs have been found to exhibit metabolic disadvantages 
that may offset the benefits of weight reduction [29,30].  Int. J. Environ. Res. Public Health 2012, 9  1672 
 
 
When comparing HRSD vs. HDSD no significant differences were observed on the glycemic 
control parameters, however, the differential effects of the HFDs was clearly manifest. Findings from 
the OGTT performed two days before the end of the experimental period showed that the highest 
glucose tolerance was found in HUFD-fed animals. Moreover, further basal determinations performed 
two days after the OGTT confirmed that HUFD group exhibited the lowest fasting glycemia and 
insulin levels. Thus, HUFD group was the best diet to improve glucose tolerance and fasting glycemia.  
The beneficial effects of HUFDs may be partially explained by the olive oil content in this diet.  
In addition to monounsaturated fatty acid (MUFA) and polyunsaturated fatty acid (PUFA),   
olive oil contains tocopherols, carotenes, and other phenolic compounds which exhibit antioxidant 
properties [31,32]. Potential mechanisms of action of olive oil are the augmentation of gastric 
emptying, reducing the glucose absorption and the increased insulin sensitivity by improving   
insulin-receptor union, cellular permeability and signaling [33]. Prieto et al. reported that olive oil 
supplementation improved glucose homeostasis and increased glucagon-like peptide-1 (GLP-1) in   
rats [34]. In humans, Garg et al. reported that a high-monounsaturated-fat diet provided lowered 
plasma glycemia in type 2 diabetics when compared to a HCD [35]. These olive oil favorable effects 
on glucose homeostasis involve the increased secretion of GLP-1 [36].  
A few years ago, postprandial glycemia peaks were only attributed to the simple carbohydrates like 
mono- or di-saccharides as fructose or sucrose, however, in recent years it has been known that some 
complex carbohydrates may exhibit the same hyperglycemic peaks when they are digested rapidly [37]. 
The rapid catabolism of highly refined corn starch used in the formulation of HDSD might explain the 
high levels of fasting insulin and fasting glycemia found after treatment. On the other hand, the native 
banana starch (NBS) used in this study has demonstrated beneficial effects on glycemic and insulin 
response in animal models as well as in diabetic subjects [19-21]. The beneficial effects of NBS could 
be attributed to the short chain fatty acid production during the colonic fermentation, being these acids 
associated with the increased production of GLP-1, cholecystokinin, adiponectin, leptin and other 
incretins [38]. 
Like the observed effects of the different components of high-fat diets to modify glycemia control 
parameters, the differential effects of the HCDs were more important on serum and hepatic lipids. 
Although, we expected that HFDs did increased serum TAG or cholesterol levels no changes were 
observed compared to the CD group. However, the HDSD increased serum and hepatic TAGs 
concentration whereas the HRSD lowered both of them (p < 0.05). The HRSD group exhibits also a 
tendency to reduce serum cholesterol and HDL-cholesterol levels as well as a tendency to reduce 
hepatic cholesterol. Taken together these results suggest that the composition of the high-carbohydrate 
diet is as important as the composition of the high-fat diets to affect metabolic control and insulin 
resistance. Further longer studies using NBS and an unsaturated-fat diet are needed in other animal 
models before extrapolating these results to subjects at high risk in order to prevent or reduce chronic 
complications by improving metabolic control and insulin resistance. On the other hand, our results 
confirm the tight interaction between carbohydrate and lipid metabolism. Any problem arising in either one 
of these processes almost invariably results in serious changes in the other metabolic pathways.  
Limitations of the present study include the lack of some measure of body adiposity which would 
have given the possibility to observe whether the differences in body weight were related to changes in 
body fat. Moreover, the differences between food consumption HCDs and HFDs effects might be Int. J. Environ. Res. Public Health 2012, 9  1673 
 
 
skewed by a little difference in the protein content between these diets, in the case of HFDs there is a 
18.6% protein but for HCDs a 21.6% was used.  
5. Conclusions 
In conclusion, after an 8-week administration, HFD and the HCD produced similar effects in 
reducing body weight gain, in spite of the different caloric consumption. The most beneficial effects 
on glycemic control were observed after the consumption of HUFD, whereas the HRSD exhibited the 
most anti-atherogenic effects in reducing serum and hepatic lipids. These findings are a manifestation 
of the complex interrelation between carbohydrates and lipid metabolism, since it is impossible to alter 
one of them without changing the other. In addition, not only fat composition is important because its 
deleterious effect on glycemic and lipidic control but the type of carbohydrate is determinant on the 
metabolic control. 
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